Methods: A retrospective analysis of clinical data evaluating long-term glaucomatous progression in POAG patients who: were previously in a 24-hour study of the authors (IOP readings at 2/6/10 AM and 2/6/10 PM); had ≥ 3 treated 10 AM (± 1 hour) IOP measurements over 5-years following an untreated 24-hour baseline; and had a treated 24-hour curve with a 10 AM IOP ± 2 mm Hg within the 10 AM mean IOP over 5-years.
INTRODUCTION
Peak intraocular pressure has recently been evaluated as being a potential risk factor for long-term glaucomatous progression for which there are several general lines of supportive evidence: first, Stewart and associates have shown in two studies that long-term, five-year peak pressure was an independent risk factor; and second, the Advanced Glaucoma Intervention Study (AGIS) showed a peak pressure of ≤ 18 mm Hg, associated with a mean pressure of 12.8 mm Hg, to be the best combination to prevent progression, although the independence of the peak pressure was not evaluated (1) (2) (3) .
Despite these findings there is not uniform acceptance regarding the importance of the peak pressure within the ophthalmic community. This is because, at least in part, not all studies have shown peak pressure to be an independent risk factor (4-6).
Further, several other problems exist when utilizing peak pressure clinically. First, unlike the mean pressure we do not have an exact target for the peak pressure to prevent glaucomatous progression; and second, since performing 24-hour curves is not practical clinically, which daytime time point(s), or combination of time points, physicians can use to assess the peak has yet to be described. Ideally, 24-hour studies might furnish information to clinicians regarding which time points they could monitor themselves to better evaluate pressure control and improve treatment to reduce the rate of glaucoma progression.
The primary purpose of this study was to evaluate the effect of 24-hour peak intraocular pressure on the progression of primary open angle glaucoma and the 24 hour time points that best predict peak pressure.
MATERIALS & METHODS

Patients
The design was a retrospective analysis that included one center in Greece and one in Italy. IRB approval was not required due to the retrospective study design. We included patients Konstas Peak intraocular pressure and progression 4 who: were diagnosed with primary open-angle glaucoma; were previously included in the database of 24-hour studies of the authors (AGPK, WCS, LQ) and who were included in published 24-hour trials; had five-years of available follow-up with at least three 10 AM (±1 hour) intraocular pressure measurements on treatment over the first five-years following the initial untreated baseline; had available an untreated baseline 24-hour curve at the beginning of the follow-up phase; had available a treated 24-hour study with a 10 AM pressure (in at least one treated arm) that was ± 2 mm Hg within the mean chronic intraocular pressure over five-years (or until progression) in at least one eye; and was > 21 years of age.
Patients were excluded from this trial who had: any abnormality that prevented reliable applanation tonometry in the study eye; intraocular conventional or laser surgery three months prior to the start of data collection; media opacity preventing reliable baseline optic nerve or visual field evaluation; primary, acute or chronic angle closure or exfoliation glaucoma; secondary or congenital glaucoma; known occludable angles by gonioscopy or presence of any other clinically significant angle abnormalities. Patients also were excluded who; or had presence of cataracts that would interfere with the interpretation of the data or the evaluation of the progression.
Procedures
All data was derived from a database of patients included in prior 24-hour studies performed by authors over the past 12-years. Data collection began from the first available patient untreated 24-hour curve in the database and continued consecutively and chronologically. All prospective 24-hour studies had the same 4-hour interval between 24-hour time points (2/6/10 AM as well as 2/6/10 PM). All pressures were measured in a masked fashion with Goldmann applanation tonometry. All patients in the databases were reviewed and all those meeting the inclusion and exclusion criteria were utilized for this analysis. In total 325 patient records were reviewed for this study from the 24-hour pressure curve databases.
To evaluate the influence of the peak pressure, we used the first untreated 24-hour
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Peak intraocular pressure and progression 5 pressure curve and the treated 24-hour pressure curve (± 2 mm Hg) that best reflected the mean pressure over the five-year follow-up that was measured between 9-11 AM. We chose the 10 AM pressure because it generally reflects the highest 24-hour pressure over the 24-hour curve in Mediterranean countries (7, 8) . We then matched the 10 AM intraocular pressures from the 24-hour pressure curves that was closest to the mean five-year 10 AM intraocular pressure.
This enabled us to approximate a 24-hour curve that was roughly similar to the patient's 24-hour curve on their routine prescribed treatment.
All 10 AM visits during the five-year follow-up period were analyzed for non-progressed patients and up to the time of progression for patients in whom progression occurred. Analysis stopped with progression to gain an understanding of the 24-hour pressure curve characteristics that led to progression.
During the five-year follow-up period, progression was determined from the patient records based on clinical interpretation by each individual investigator. Generally, criteria for progression were an increase in thinning of the neural rim or a worsening of glaucomatous visual field loss. In patients with total glaucomatous cupping and diffusely depressed visual fields, worsened visual acuity was used also as a sign of progression (9) . Typical exam techniques were used including both sterioptic Volk lens and disc photograph examinations.
Automated threshold techniques were used for the visual field examination. The chronic pressures and medical history collected from patient documents were entered into an excel spreadsheet.
Statistics
PRN Pharmaceutical Research Network, LLC, analyzed the data. All data analyses were two-sided and had an α-level of 0.05. The eye with the highest intraocular pressure at baseline was selected from the database to be used for this study. If the intraocular pressure of both eyes was the same at baseline, the right eye was selected. All analyses were between progressed and non-progressed groups of patients.
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The primary efficacy variable was the mean 24-hour peak intraocular pressure, which was analyzed by a one-way ANOVA test for repeated measures (10) . Secondary efficacy variables, additional mean pressure evaluations and patient age, were also analyzed by a oneway ANOVA test (10) . Gender and patient history parameters were analyzed with a Chi-square test. Race and the number of patients progressing or non-progressed at an individual pressure level, and the number of patients with a peak pressure at each time point over the 24-hour curve were described and not analyzed statistically.
A multivariate regression analysis was performed to access the risk factors associated with glaucomatous progression (JMP, Version 5, Cary, NC) (11) . This test was used to explore demographic, clinical and treatment features as risk factors for progression.
RESULTS
Patients
Patient baseline characteristics for progressed and non-progressed patients are shown in Table 1 . There were no statistically significant differences for any baseline patient characteristic evaluated in this study (P>0.05). In total 325 patient records were screened for this study from the 24-hour pressure curve databases, but 174 were excluded based on criteria specified in the Materials & Methods, leaving 151 to be included in the analysis.
Peak intraocular pressure
The mean 24-hour peak pressure was 19.9 ± 2.7 mm Hg for progressed and 18.3 ± 2.0 mm Hg for non-progressed patients (P<0.001). Table 2 shows the number of patients who had their peak intraocular pressure at each 24-hour time point in both progressed and non- little from the entire patient group. Table 3 shows the number of patients with their peak 24-hour pressure at one of three daytime time points, or at a combination of daytime time points (10 AM, 2/6 PM). The table also demonstrates the number of patients who had their 24-hour peak pressure measured above their peak daytime pressure. Measuring the pressure at all three daytime time points identified approximately 80% of the 24-hour peak pressures. Adding 2 mm Hg to this peak pressure estimated the highest potential 24-hour peak pressure for 98% of all patients and 96% of progressed patients. The percentage of patients who had their 24-hour peak identified essentially did not change when only patients were evaluated who had their mean pressures controlled to < 18 mm Hg.
The number of progressed and non-progressed patients over five-years at each 24-hour peak pressure is shown in Figure 1 and for daytime peak in Figure 2 . Patients who had a peak 24-hour or daytime pressure of ≤ 18 mm Hg generally progressed less (both 78% nonprogression) than those with a higher pressure.
Mean intraocular pressure
The average intraocular pressures at each time point and for the 24-hour pressure curve are shown in Table 4 . Progressed patients showed a significantly higher pressure over the Further, using the daytime peak pressure, together with the daytime mean pressure, to better identify progressed patients added little (78% non-progression rate) beyond those found Konstas Peak intraocular pressure and progression 8
by the daytime mean pressure alone (75 non-progression rate).
Regression analysis
A multivariate regression analysis showed only 24-hour peak intraocular pressure was an independent risk factor for progression (P=0.002) ( Table 5 ). Non-significant variables were age, gender, mean daytime intraocular pressure, geographic location and all individual medicines.
DISCUSSION
The purpose of this study was to evaluate the effect of the 24-hour peak intraocular pressure in the progression of primary open angle glaucoma and the 24 hour time points that best predict peak pressure.
This study showed that peak pressure may be an independent risk factor associated with progression. This is consistent with some past research, but not with other studies that have indicated that peak pressure was not an independent risk factor for progression (1,2,4,12,13).
Patients with a peak 24-hour pressure of ≤ 18 mm Hg had a 78% non-progression rate.
The peak pressure occurred most frequently at the 10 AM time point. However, 20% of all patients, and 17% of progressed patients, had their peak pressure at a time point(s) only outside normal office hours (10 PM, 2/6 AM). This is consistent with several past studies, which indicated that peak pressure may fall out of normal office hours (5,14-16).
Unfortunately, the 24-hour peak pressure has been difficult to use clinically for several reasons including that no treatment goal has been identified for this parameter and measuring pressures over the 24-hour curve is logistically difficult. We attempted to make peak pressure more usable by identifying a target pressure for the daytime peak pressure that would assist the physician in using this parameter clinically without having to measure pressures during nighttime hours.
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To the authors' surprise, in terms of numbers of patients, those with a with a peak pressure ≤ 18 mm Hg, the peak daytime pressure provided the same non-progression rate (78%) as the 24-hour peak, and essentially the same as the mean daytime pressure (75% nonprogression rate). The narrow difference between the value of 24-hour and daytime peak pressures was supported by our finding that if 2 mm Hg was added to the daytime peak pressure it identified the highest potential 24-hour peak pressure for 98% of all patients and 96% of progressed patients (Table 3 ). In contrast, the narrow difference between the daytime mean and peak pressures was supported by our finding that using these two parameters together did not help discriminate further between progressed and non-progressed patients.
This study also showed, similar to several past investigations, that mean intraocular pressure is higher long-term in progressed primary open-angle glaucoma patients (6, 13, 17, 18) .
Also, similar to several prior studies, the daytime mean pressure level that best prevented progression was approximately ≤ 18 mm Hg (75% non-progression) (6).
In contrast, the mean 24-hour pressure that best prevented progression was approximately 16-17 mm Hg (75% non-progression). This may have resulted because daytime pressures are typically higher than nighttime pressures, when measured by Goldmann tonometry, and the nighttime pressures may have reduced the 24-hour average. Interestingly, mean nighttime pressures at 10 PM and 2 AM did not differentiate between progressed and non-progressed patients (19) .
What may our data mean clinically? First; the 24-hour and daytime peak pressure (78% non-progression rates) and for the mean daytime pressure (75% non-progression rate) that bests discriminates between progressed and non-progressed patients appears to be approximately ≤ 18 mm Hg. Second, using the daytime peak pressure to further refine the daytime mean pressure in patients controlled to ≤ 18 mm Hg adds little in identifying more nonprogressed patients (only 78% non-progression rate using both the daytime mean and peak pressures together). Third, measuring the pressure during nighttime hours finds only a higher Konstas Peak intraocular pressure and progression 10 peak in 20% of cases than measuring daytime pressures at 10 AM, 2/6 PM. Further the daytime peak pressure generally will be within 2 mm Hg of the 24-hour peak. Since the 24-hour peak pressure that bests discriminates between progressed and non-progressed patients appears to be approximately the same as the daytime peak pressure, the 24-hour pressure curve probably need not be measured routinely unless the physician is suspicious of an unusually high nighttime pressure (e.g. unexplained progression at seemingly well controlled daytime pressures). Fourth; although a patient might have their mean daytime pressure controlled to ≤ 18 mm Hg, some patients may not tolerate a peak above 18 mm Hg at any daytime time point.
These findings are consistent with the AGIS study, which found little progression at approximately a mean pressure of 13 mm Hg and a peak pressure below 18 mm Hg at all times (3). Last; even pressures treated to ≤ 18 mm Hg failed to prevent progression in all cases. This indicates that further risk factors most likely remain to be elucidated, or the need for better pressure characteristics (i.e. lower mean and peak 24-hour pressures), to explain why some patients still progress at seemingly well controlled pressure levels (3).
This study suggests that daytime peak intraocular pressure may be clinically important in Although this study utilized the largest 24-hour patient data described to date, by our knowledge, the sample size still was relatively small. Further, our study did not evaluate mean and peak pressure in a prospective manner. Other risk factors probably still exist (e.g. 
Figure 1
The number of patients who progressed (grey) and non-progressed (black) over five-years at each peak pressure for the 24-hour curve.
Figure 2
The number of patients who progressed (grey) and non-progressed (black) over five-years at daytime time points for the peak intraocular pressure.
Figure 3
The number of progressed (grey) and non-progressed (black) patients for the mean intraocular pressure for the 24-hour curve.
Figure 4
The number of progressed (grey) and non-progressed (black) patients at each mean pressure as measured from the daytime time points (10 AM, 2/6 PM) 
